Sage Healthspan Launches AI-Powered, Privacy-First Wellness App to Bridge Critical Gaps in Preventative Healthcare
Orange County, California, June 27, 2025 (GLOBE NEWSWIRE) -- Sage Healthspan, a California-based digital health company, announced its precision health app, now available for free on Apple's App Store. Designed to address notable shortcomings in modern healthcare delivery, Sage introduces a privacy-first, on-device artificial intelligence (AI) platform aimed at helping users interpret their blood work, monitor health trends, and optimize wellness without sacrificing data security.
A Glimpse into Sage Healthspan Analytic Features
In an era where preventative healthcare is increasingly prioritized, many individuals still lack access to timely, comprehensible, and actionable insights from their routine lab results. Sage Healthspan identified a persistent issue: although patients regularly undergo blood tests, most are only contacted if major abnormalities are flagged. This approach overlooks nuanced health patterns and early indicators of disease, leading to missed opportunities for early intervention.
'Instead of waiting for symptoms to appear, Sage empowers users to engage proactively with their health data,' said Megan Haas, Media and Communications Lead at Sage Healthspan. 'The AI platform helps transform routine lab work into structured insights, encouraging users to take control of their health trajectory in a secure, comprehensible, and private way.'
Closing the Loop Between Data and Action
Sage allows users to upload or photograph existing lab results directly from their Apple devices. The platform then interprets the data using local AI algorithms, never uploading personal information to the cloud, providing summaries, visualizations, and tailored recommendations. This includes suggestions for lifestyle adjustments, supplement considerations, or follow-up testing to support long-term wellness goals.
Importantly, Sage differentiates itself by emphasizing a 'privacy-first' model. All health data remains on the user's device, enabling secure HIPAA-compliant analysis. In a climate where 78% of healthcare executives name cybersecurity as a top priority, Sage's on-device processing offers a practical alternative to cloud-based health apps.
A Comprehensive Health Insight Engine
Sage's AI generates insights across an extensive array of health and biomarker categories, including cardiometabolic health, inflammation, blood sugar, autoimmunity, nutrient status, thyroid health, kidney and liver function, and more. As users contribute additional data over time, Sage builds a personalized timeline, allowing for trend detection and wellness optimization rooted in longitudinal analysis.
A unique feature of Sage's platform is its lab test ordering capability. Users can independently request advanced biomarkers that are often excluded from standard panels. These include cardiovascular indicators such as ApoB and Lp(a), fasting insulin and HOMA-IR for metabolic health, thyroid and sex hormone assessments, and nutritional markers like vitamin D and omega-3 fatty acid levels.
The Growing Importance of Intelligent Health Analytics
Recent studies show that 67% of patients report confusion over their lab results, with 61% struggling to understand medical terminology. Additionally, with primary care visits averaging only 15-18 minutes, providers have limited time to address complex, individualized wellness concerns. Sage Healthspan aims to complement, not replace, medical professionals by offering supportive tools that clarify and contextualize lab data for users.
From a broader healthcare systems perspective, early detection is increasingly recognized as a critical cost-saver. Nearly 90% of the United States' annual $4.5 trillion healthcare expenditure is tied to chronic conditions. Sage's focus on biomarker-based early detection aligns with evolving industry goals: identifying risk before symptoms arise and enabling targeted, timely action.
Positioning in the Era of Medicine 3.0
The emergence of AI in health represents a shift toward what experts call 'Medicine 3.0,' a paradigm that emphasizes prevention, personalization, and patient empowerment. Sage Healthspan embodies this transition. By integrating intelligent health analytics into everyday devices and eliminating the need for cloud computing, the company delivers accessible wellness insights while maintaining robust privacy protections.
Sage Healthspan is currently available exclusively for iOS on Apple's App Store. Users are encouraged to begin by uploading pre-existing lab results to generate immediate health insights. For more information or to learn how Sage can support a wellness journey, visit sagehealthspan.com.
About Sage Healthspan
Sage Healthspan is a health technology company based in California focused on closing critical gaps in preventative healthcare. Through its privacy-first AI app, Sage empowers users to understand and act on their blood work, providing structured insights across a range of biomarkers to support health optimization and early detection. Sage's core mission is to make personalized wellness both accessible and secure.
Sage Healthspan Logo
Media Contact Company Name: Sage Healthspan Contact Person: Megan Haas Email: [email protected] Country: United States Website: http://sagehealthspan.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Forbes
26 minutes ago
- Forbes
Crypto IPO: 3 Things You Need To Know About The IPO Season
The Wall Street sign in the Financial District of Lower Manhattan in New York City. Circle's successful IPO has sent a signal. A strong one. The crypto world is heating up again, but this time, it's happening on Wall Street. Crypto companies are making a comeback after a long period of regulatory uncertainty. Circle, the stablecoin issuer, has initiated a global sensation in capital markets. Understandably so. Circle's recent debut on the New York Stock Exchange as CRCL was impressive, to say the least. CRCL's share price skyrocketed nearly 600% from its IPO price of $31 to a high of $215 during the day. With a market cap of $45 billion, Circle has quickly become the representative of a new trend, giving rise to a crypto IPO season. Was it a flashy debut? Yes, and for all good reasons. Circle's IPO, the biggest in recent history, marks a major milestone in the industry's journey toward mainstream acceptance. USDC, Circle's flagship stablecoin, is backed by over $32 billion in reserves and is already a core component of onchain finance, serving as a payment medium that dominates the whole crypto ecosystem. But there are three key things you need to know about this year's IPO season to understand this phenomenon. 1. It's Only The Beginning Of Crypto IPOs Just days after Circle's IPO, Gemini, the crypto exchange founded by Tyler and Cameron Winklevoss, confidentially filed paperwork for its own IPO in the U.S. At the same time, all eyes moved onto Kraken, which is reportedly preparing to go public sometime in early 2026. Another company making moves is BitGo, a regulated U.S. crypto custodian. Back in February, reports suggested it was aiming for an IPO as early as 2025. A few other names also stand out as potential IPO contenders: These companies span the entire spectrum, from custody and analytics to wallets and infrastructure. What they have in common is a fresh appetite for public capital and growing investor interest, especially institutional one. As one analyst put it, 'After watching Circle's stock take off, any crypto firm with a clear business model is now looking at the IPO route seriously.' 2. The IPO Process Although the range of companies participating in the IPO summer is wide, crypto exchanges are leading the charge in pursuing US stock market listings. Think Gemini, Kraken, Bullish Global, FalconX, and Bithumb. These types of businesses are particularly well-positioned for public listing due to their strong cash flows, large customer bases, and stable business models that appeal to traditional investors. There are different ways companies can go about executing public offerings. Traditional IPOs remain the gold standard, particularly for mature companies with strong compliance records and established business operations. However, this process is very complex and time-consuming, making it most suitable for larger platforms with proven business models and solid profitability. That's why for smaller cryptocurrency companies seeking a faster path to public markets, reverse mergers have become a popular alternative. Companies, such as TRON, have successfully leveraged this approach by acquiring existing public companies to quickly gain access to the stock market, bypassing the lengthy traditional IPO process. Meanwhile, some companies are opting for direct listings. This is shown by Kraken's approach, which achieved a $16.2 billion valuation. They were able to create market liquidity for their shares without the need to raise new capital, making it ideal for firms that don't necessarily require additional funding but instead want to provide exit opportunities for existing shareholders. 3. High Crypto IPO Expectations Circle has definitely set a high bar. Its stock soared, boosting confidence across the crypto sector. But Circle isn't your typical crypto company. Their stablecoin, USDC, is a go-to onchain payment solution. In addition, its business model—earning yield on reserve assets—is easy for traditional finance folks to understand. Retail and institutional demand are growing, and with a government no longer hostile, investors see 2025 as the year when crypto companies leverage the IPO playbook. The dramatic shift in institutional adoption is particularly compelling. As of January 2025, 86% of institutional investors reported having exposure to digital assets or planned to make digital asset allocations later in the year. Additionally, recent success stories have proven that crypto companies can achieve substantial valuations in public markets. Circle's roughly $1.1 billion public listing formed the largest crypto IPO in recent history, sparking high expectations among industry experts that more digital asset companies will soon follow suit. However, only time will tell if this crypto IPO summer turns into an IPO supercycle, but Coinbase being the best performing S&P500 stock in June is definitely a promising sign.
Forbes
26 minutes ago
- Forbes
‘Huge' BlackRock Crypto Bombshell Suddenly Hurtling Toward Bitcoin At Key Price ‘Turning Point'
Bitcoin has bounced back in recent weeks, surging as serious U.S. dollar collapse fears drive billionaire interest in bitcoin. Front-run Donald Trump, the White House and Wall Street by subscribing now to Forbes' CryptoAsset & Blockchain Advisor where you can "uncover blockchain blockbusters poised for 1,000% plus gains!" The bitcoin price has soared toward its all-time high of $112,000 per bitcoin, with traders betting a looming Federal Reserve flip will turbo-charge the crypto market. Now, as U.S. president Donald Trump issues a surprise crypto prediction, bitcoin and crypto are braced for a 'huge' BlackRock crypto market bombshell that has suddenly appeared on the 'horizon.' Sign up now for the free CryptoCodex—A daily five-minute newsletter for traders, investors and the crypto-curious that will get you up to date and keep you ahead of the bitcoin and crypto market bull run BlackRock chief executive Larry Fink has become one of the most bullish bitcoin price voices on Wall ... More Street in recent years. In-kind redemptions for the bitcoin and crypto exchange-traded funds (ETFs) that have taken Wall Street by storm over the last 18 months could be coming soon, according to U.S. Securities and Exchange Commission (SEC) commissioner Hester Peirce. 'I can't prejudge, but we hear that there's a lot of interest,' Peirce, who heads up the SEC's crypto task force, said on stage at a Bitcoin Policy Institute event, adding that in kind bitcoin and crypto ETFs are now 'on the horizon.' In-kind redemptions allow investors to exchange ETF shares directly for the underlying asset rather than receiving cash, which is currently the case for the spot bitcoin and crypto ETFs approved by the SEC in early 2024—a change described as 'huge' by Bloomberg Intelligence ETF analyst Eric Balchunas. In-kind redemptions for bitcoin and crypto funds would make it cheaper and quicker for traders to buy and sell ETF shares, potentially making them more attractive to institutional investors on Wall Street. Earlier this year, BlackRock, which has dominated the spot bitcoin ETF market with its $75 billion IBIT fund, asked the SEC to permit in-kind creations and redemptions for bitcoin ETFs, instead of having to use cash, with the likes of Fidelity and other smaller bitcoin and crypto ETF providers following suit. "Those (forms) are going through the process now," Peirce said. Sign up now for CryptoCodex—A free, daily newsletter for the crypto-curious The bitcoin price has rocketed to an all-time high this year, helped by BlackRock's massive $75 ... More billion bitcoin exchange-traded fund (ETF). BlackRock, which manages after around $10 trillion worth of assets for investors, spearheaded Wall Street's campaign to bring a long-awaited spot bitcoin ETF to market in 2023, with a fleet of funds debuting in January 2024 that now hold 1.4 million bitcoin worth $152 billion. BlackRock's fund alone holds around 3% of the 21 million bitcoin that will ever exist, worth almost $75 billion at the current bitcoin price, which some have warned could be giving BlackRock outsized control over the network. Meanwhile, the combined bitcoin price and crypto market is on the verge of a 'turning point' as it hits $3.4 trillion, according to one analyst. 'The $3.4 trillion to 3.55 trillion range is a turning point, which has activated sellers and prevented the market from consolidating higher,' Alex Kuptsikevich, FxPro chief market analyst, said in emailed comments. 'Since the end of Wednesday, bitcoin has been testing the $108,000 mark, but it will sell off when it touches this level. Over the past couple of days, we have seen a smooth but steady intraday uptrend, accompanied by heavy buying from medium—and long-term investors. We see this as a sign of buying by professional market participants and link it to strengthening stocks, which increases the likelihood of reaching $110,000 or even $112,000 as early as this week.'
Yahoo
26 minutes ago
- Yahoo
Is META Stock a Buy, Sell, or Hold as Meta Platforms Launches New v-JEPA 2 AI Model?
As the artificial intelligence (AI) race accelerates toward advanced machine intelligence (AMI), tech giants are pushing boundaries to create agents that can reason more like humans. A key piece of this puzzle is physical reasoning, essential for AI systems to navigate and act within the real world. Meta Platforms (META) has stepped into this frontier with the launch earlier in June of its Meta Video Joint Embedding Predictive Architecture 2 (V-JEPA 2), a powerful video-based world model that helps machines anticipate how the physical world behaves. Unlike language-only models, V-JEPA 2 learns from video data to predict object dynamics and human interactions using latent-space simulation. It allows robots to 'think before they act,' performing tasks like picking up and placing objects in unfamiliar environments. Ditch Big Tech and Buy These 3 Popular Stocks in 2025 Instead Dear Nvidia Stock Fans, Watch This Event Today Closely Can Broadcom Stock Hit $400 in 2025? Tired of missing midday reversals? The FREE Barchart Brief newsletter keeps you in the know. Sign up now! Meta's bold move also includes new benchmarks to accelerate physical reasoning research, plus, a reported $14.3 billion investment in Scale AI, signaling CEO Mark Zuckerberg's intent to anchor AI deeply into Meta's ecosystem. But does this push into physical AI make META stock a buy, or should investors wait on the sidelines? Meta Platforms (META) has grown from a college social network into a global tech powerhouse, redefining how billions of people communicate. The California-based tech titan now oversees a sprawling digital empire, anchored by social media giants such as Instagram, WhatsApp, and Messenger, and is charging ahead into the future with ambitious bets in AI, augmented reality, and the metaverse. What began with a newsfeed has evolved into a full-scale push to shape how humans and machines interact in the next era of connectivity. That future-facing focus seems to be paying off. Meta's shares have surged more than 700% over the past decade. In 2025, META has so far delivered a standout 21% YTD gain, and over the past year, the stock has skyrocketed 38.8%, handily beating not just some of its tech peers, which flinched under pressure, but also the S&P 500 Index's ($SPX) returns. The surge was fueled by rising ad revenues, deeper AI integration, and investor faith in its metaverse roadmap. Meta's Q1 2025 earnings report, released on April 30, came out swinging, crushing expectations and fueling a 4.2% jump in the stock the very next day. Revenue climbed 16% year over year to $42.3 billion, beating Wall Street's estimate of $41.4 billion. But the real knockout punch came from EPS, soaring 37% to $6.43, 23.2% higher than forecasts. Meta's ad engine is still humming, with impressions up 5% and the average price per ad jumping 10%. User growth remains rock solid too, as, in March, daily active users across the company's app family reached 3.4 billion, up 6% year-over-year. Meta tightened the screws on costs and it paid off. Its operating income surged 27% to $17.56 billion, lifting margins to 41%. Plus, with $70.2 billion in cash and marketable securities and just $28.8 billion in long-term debt, Meta heads deeper into 2025 with a strong balance sheet and momentum on its side. CEO Mark Zuckerberg highlighted AI as the driving force behind the company's renewed energy, particularly Meta AI and its growing line of smart glasses. Meta AI has already hit nearly 1 billion monthly users. But the real story may be what's next. Looking ahead, management anticipates Q2 revenue to be between $42.5 billion and $45.5 billion, signaling continued strength. Plus, with capex now projected to be between $64 billion and $72 billion for 2025, Meta is going full throttle into AI infrastructure and next-gen computing. Analysts monitoring the social media company project its revenue for Q2 to be around $44.5 billion, and EPS for the quarter is anticipated to rise by 11.4% year over year to $5.75. Looking further ahead to fiscal 2025, the bottom line is expected to climb to $25.25 per share, up 5.8% annually. AI-driven robotics and autonomous systems are reshaping industries - from logistics to consumer tech - with speed and adaptability becoming the new gold standard. Meta's V-JEPA 2 steps into this evolving space as a potentially disruptive force. What truly elevates V-JEPA 2, however, is Meta's decision to open-source the framework. By releasing code, benchmarks, and training data, Meta is fostering a collaborative ecosystem, one that could fuel innovation far beyond its own walls. Yet this openness is a double-edged sword. It lowers barriers for startups but also gives its competitors access to refine their systems faster. For Meta, the model is a strategic leap, but long-term success depends on how well it is integrated, scaled, and monetized. Meta's ambition to dominate AI just got Wall Street's nod. Recently, Bank of America hiked its price target to $765, citing easing macroeconomic worries and expanding valuations. Buzz around Meta's roughly $14.3 billion Scale AI investment only adds fuel, signaling Zuckerberg's intent is to lead the AI race, not follow. Wall Street has got its foot on the gas for Meta. The stock holds a 'Strong Buy' consensus, signaling full-speed-ahead confidence in its trajectory. Of the 54 analysts offering recommendations, 45 are giving it a solid 'Strong Buy,' three advise a 'Moderate Buy,' four suggest a 'Hold,' and only two advocate a 'Strong Sell.' META's average analyst price target of $711,88 implies modest 2.4% potential upside. However, the Street-high price target of $935 suggests that the stock can still rally as much as 32% from here. On the date of publication, Sristi Suman Jayaswal did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
